FDA approves Kcentra for urgent reversal of anticoagulation in adults

Author(s):

On April 29, the U.S. Food and Drug Administration (FDA) approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. Plasma is the only other product approved for this use in the United States; Kcentra doesn’t require blood group typing or thawing, so it can be administered more quickly than frozen plasma. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here